Phosphoproteomic signatures for early detection and stratification of AML

Scott Davis

Exposures from Chernobyl

Leukaemia

Pediatric oncology or childhood cancer Radiation Oncology

Carl E Allen

Redefining Langerhans Cell Histiocytosis as a Myeloid Dysplasia and Identifying Biomarkers for Early Detection and Risk Assessment

Leukaemia

Laura B Freeman

Pooling project of NCI and Cross-Canada studies

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Dharmendra Dingar

In vivo BioID identifies novel c-MYC interacting partners

Trachea, bronchus and lung Leukaemia Colorectum Breast

Lixin Wan

A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment

Leukaemia

Sophie Papa

Clinical Translation of Gene Modified T-cell Therapy for Solid Tumours

Prostate Leukaemia

Mary V. Relling

Center for Precision Medicine in Leukemia (CPML)

Leukaemia

Pathology

Aaron David Schimmer

Targeting the mitochondrial proteasome, ClpP, in AML

Leukaemia

Lynn Goldin

Autoimmune Diseases and Risk for Lymphoma and Other Cancers

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies